Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GSK1265744 (Cabotegravir, CAB) for Named Patient/Compassionate Use in HIV

NCT03462810 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT03462810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03462810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GSK1265744 (Cabotegravir, CAB) for Named Patient/Compassionate Use in HIV
Lead sponsor
ViiV Healthcare
Phase
Expanded access
Overall status
Available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

infection, human immunodeficiency virus